Dixon Hubard Feinour & Brown Inc Dexcom Inc Transaction History

Dixon Hubard Feinour & Brown Inc

  • $842 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
BUY
$95.51 - $112.95 $67,716 - $80,081
709 Added 13.19%
6,084 $2.51 Million
Q2 2020

Jul 31, 2020
BUY
$62.68 - $105.34 $4,074 - $6,847
65 Added 1.22%
5,375 $2.25 Million
Q1 2020

May 15, 2020
BUY
$47.79 - $75.63 $253,764 - $401,595
5,310 New
5,310 $1.43 Million

Others Institutions Holding DXCM

# of Institutions
1,021
Shares Held
352M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email